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To identify novel cytokine-related genes, we searched the set of 60,770 annotated RIKEN mouse cDNA clones
(FANTOM2 clones), using keywords such as cytokine itself or cytokine names (such as interferon, interleukin,
epidermal growth factor, fibroblast growth factor, and transforming growth factor). This search produced 108
known cytokines and cytokine-related products such as cytokine receptors, cytokine-associated genes, or their
products (enhancers, accessory proteins, cytokine-induced genes). We found 15 clusters of FANTOM2 clones
that are candidates for novel cytokine-related genes. These encoded products with strong sequence similarity to
guanylate-binding protein (GBP-5), interleukin-1 receptor-associated kinase 2 (IRAK-2), interleukin 20 receptor 
isoform 3, a member of the interferon-inducible proteins of the Ifi 200 cluster, four members of the
membrane-associated family 1-8 of interferon-inducible proteins, one p27-like protein, and a hypothetical
protein containing a Toll/Interleukin receptor domain. All four clones representing novel candidates of gene
products from the family contain a novel highly conserved cross-species domain. Clones similar to growth
factor-related products included transforming growth factor -inducible early growth response protein 2
(TIEG-2), TGF-induced factor 2, integrin -like 1, latent TGF-binding protein 4S, and FGF receptor 4B. We
performed a detailed sequence analysis of the candidate novel genes to elucidate their likely functional
properties.
[Supplemental material is available online at www.genome.org]
Cytokines are polypeptides secreted by immune cells that
function as humoral regulators modulating functional activi-
ties of cells and tissues including cellular interactions and
processes. Cytokine genes often encode functional variants
through alternative splicing, resulting in proteins that may
have slightly different biological activities (Ibelgaufts 1999).
Cytokines are typically mutually unrelated, but some may be
grouped in families.
Activated cytokine-producing cells often release many
different cytokines, resulting in complex networks of inter-
acting signals. Cytokines are crucial in immune cell activa-
tion, cell-to-cell communication, signal transduction, mito-
sis, cell survival, death, and transformation. In addition to
their involvement in initiation and regulation of immune re-
sponses, cytokines are also important in embryogenesis, or-
gan development, and neuronal processes (Ibelgaufts 1999).
Clinical uses of cytokines include application in hematopoi-
esis (Smith 1990), tumor immunotherapies (Cao et al. 1998;
Rosenberg 2001; Homey et al. 2002), bone marrow transplan-
tation (Miyazaki and Kato 1999), gene therapy (Jeschke et al.
2001), and vaccine formulations (Knutson and Disis 2001).
The function of a particular cytokine can be assessed in
vivo in transgenic or gene knock-out animals by studying the
effects of an excess or lack of a particular cytokine gene prod-
uct. It is of great importance for cytokine research, therefore,
that the counterparts of human cytokine, cytokine receptors,
and cytokine-related genes are identified in animals (e.g., the
mouse) suitable for genetic manipulation. Because of the re-
markable similarity between human and mouse genomes and
their closely related biochemical, physiological, and patho-
logical pathways, the mouse is an extremely useful animal
model for immunological studies.
The FANTOM2 collaboration (Okazaki et al. 2002) in-
volved functional annotation of a set of 60,770 RIKEN mouse
cDNA clones (FANTOM2 clones). The FANTOM2 data set, the
most complete picture of the mouse transcriptome to date,
provides an ideal opportunity for identification of novel
mouse genes, including cytokine-related genes. The annota-
tion process included data from microarray expression, map-
ping and protein interactions, and sequence similarity search
analyses. The annotation was performed by large-scale, com-
puterized annotation combined with manual curation by hu-
man experts. We analyzed the FANTOM2 annotations, spe-
cifically looking for novel and existing mouse cytokines and
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cytokine-related genes. In this study, we focused on genes
related to interferons (IFN), interleukins (IL), growth factors
(epidermal growth factors [EGF], fibroblast growth factors
[FGF], and transforming growth factors [TGF]), and small in-
ducible cytokines (SIC). Some cytokines, such as tumor ne-
crosis factors (TNF), belong to superfamilies that also include
non-cytokines. Because this study was based on matching cy-
tokine names from descriptions of database entries, cytokine
families that belong to broader superfamilies were excluded
from the analysis. Further study is required for a compre-
hensive analysis of all known cytokines and cytokine-re-
lated genes that have not been included in this work. The
FANTOM2 clones contained more than 100 previously iden-
tified cytokine and cytokine-related genes. We also identified
several candidates for novel mouse cytokine-related genes.
RESULTS
Of the 60,770 FANTOM2 clones, 256 had annotations that
contained a cytokine name. A total of 222 clones had high-
sequence identity (>96% over 50% length of the reference
sequence) to 108 known mouse genes, as listed in the major
databases. Of these, clones represented 27 known interferon-
related genes (Table 1). The known mouse genes in the
FANTOM2 set comprised 1 interferon (IFN-), 2 IFN receptors
(IFN receptor, and IFN receptor 2), 20 inducible/
activatable genes, and 4 other IFN-related genes. Search of the
protein translation of the GenBank database (Benson et al.
2002, as of September 2002) revealed that there were at least
15 nonredundant entries of various mouse IFNs, 10 IFN re-
ceptors, 190 IFN inducible or activatable proteins, and 60 IFN
regulatory proteins.
A total of 77 clones represented 39 known interleu-
kin-related genes (Table 2). The known mouse genes in the
FANTOM2 set comprised 11 interleukins (IL) or chains thereof
(IL-1, IL-1, IL-6, IL-7, IL-1F9, IL-16, IL-17B, IL-20, IL-23p19,
and IL-25), 19 interleukin receptors (ILR-1I, ILR-1-1, ILR-2,
ILR-2, ILR-2, ILR-4, ILR-6, ILR-7, ILR-9, ILR-10, ILR-
121, ILR-122, ILR-131, ILR-132, ILR-15, ILR-17, ILR-18-
1, ILR-21, and ILR-23p19), and 9 other IL-related genes.
Search of the protein translation of the GenBank database
revealed that there are at least 40 nonredundant entries of
mouse ILs (including variants and subunits), 50 IL receptors,
and 80 other IL-related proteins. These results are in agree-
ment with an earlier finding (Staudt and Brown 2000), which
stated that only a half of human ILs, mainly those widely
expressed, were found in the EST libraries. The ILs reliant on
the activation of immune cells, namely IL-2, IL-3, IL-5, IL-9,
IL-11, IL-12, IL-14, and IL-17, were lacking in the EST librar-
ies.
A total of 61 clones represented 23 known growth factor
(EGF, FGF, and TGF)-related genes (Table 3). The known
mouse genes in the FANTOM2 set comprised 5 growth factors
(EGF, FGF 14, FGF 15, TGF, and TGF 68 kD) and 18 other
growth factor-related genes. Search of the protein translation
of the GenBank database revealed that there are at least 140
nonredundant entries of various mouse growth factor (EGF,
FGF, and TGF)-related genes (including variants and sub-
units).
Finally, 30 clones represented 19 known small inducible
cytokine-related genes in mouse (Table 4). Search of the pro-
tein translation of the GenBank database revealed that there
are at least 38 nonredundant entries of various small induc-
ible cytokines in mouse.
Clones representing 17 known mouse cytokine-related
genes were derived from cDNA libraries from the non-obese
diabetic (NOD) mouse. All of the remaining cytokine-related
clones were derived from the C57BL/6 mouse strain. Six
known genes were only found from the NOD mouse libraries.
Clones representing a total of 11 known mouse genes were
found in both C57BL/6 and NOD mouse cDNA libraries. The
clones representing known cytokine-related genes were de-
rived from a broad variety of RIKEN cDNA libraries. These
libraries were generated from various tissues and developmen-
tal stages. Because this analysis focused on name matching
from both the FANTOM2 data set and GenBank database, we
can estimate that FANTOM2 clones cover ∼20% of existing
known cytokine-related genes. Cytokines induce cascades of
cytokine networks as well as of regulatory molecules. Often it
is unclear whether the induced molecule acts as a cytokine or
has some other regulatory role. In this study, we consider all
clones as cytokine related and did not discriminate between
the two groups.
We have also identified 15 candidate novel cytokine or
cytokine-related genes (Table 5), including 7 candidate novel
mouse IFN-related genes (13 clones), 3 candidates for novel
IL-related genes (5 clones), and 4 candidates for novel growth
factor-related genes (3 TGF- and 1 EGF-related) (16 clones). All
of the clones representing candidate novel genes were derived
from the C57BL/6 mouse and showed 96% identity over
>50% length of the reference sequence.
Interferon-related Novel Gene Candidates
The clones 1110004C05, 4930507H06, A330075D07, and
1110036C17 represent four putative novel members of the
membrane-associated family 1-8 of interferon-inducible pro-
teins (Fig. 1). Sequences of these clones showed similarity to a
variety of interferon-induced genes and proteins in human
(Lewin et al. 1991), rat (Hayzer et al. 1992), cattle (Pru et al.
2001), and trout (SPTR Q8QFL3). Members of the 1-8 family
of interferon (IFN)-inducible genes encode proteins thought
to modulate cellular growth and adhesion wound healing,
and inflammatory responses. It was hypothesized that they
may function as membrane transport proteins (Pru et al.
2001). The 1-8 proteins participate in multimeric complexes
involved in the transduction of homotypic and antiprolifera-
tive adhesion signals. Sequences of all four clones of novel
candidate members of the 1-8 family contain a novel (not
found in motif databases), motif DxxxWSxxxxxxxNxx-
CLGxxAxxxSxKSRDRKMVGDxxGAxxxxxTA that is con-
served across species (fish, rat, mouse, and human). Further-
more, sequence of the clone 1110004C05 (Fig. 1) contains the
motif YxxxxCLxI that conserves critical residues found in the
active sites of human E2 ubiquitin conjugating enzymes (Pru
et al. 2001). Sequences of the clones 4930507H06 and
1110036C17 contain similar motif FxxxxCLxI, whereas the
remaining clone A330075D07 does not contain the corre-
sponding motif. Each of the four candidate new members of
the 1-8 family showed highest similarity to a distinct database
entry and therefore each represents a distinct transcript (data
not shown). The amino acid differences between the members
of the 1-8 family at carboxy- and amino-termini may contribute
to subtle functional differences or cellular localization.
Sequence of the clone 2310061N23 showed similarity to
the gene for the IFN--inducible protein p27-h found in ham-
ster cardiomyopathic tissue (Denovan-Wright et al. 2000) and
human gene TLH29 (Q9H2X8) from liver tissue (Fig. 2). The
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p27-h gene showed increased expression in cardiac and skel-
etal muscle tissue undergoing active necrosis. These se-
quences are similar (data not shown) to the human IFN--
inducible protein p27 (GenBank NM_005532) shown to have
increased expression in breast carcinoma (Rasmussen et al.
1993). The p27 protein is relatively small (11 kD) and highly
hydrophobic. The p27-like mRNA is present in multiple tis-
sues treated with the TNF, and it was speculated that these
genes may be linked to inflammation related to the necrotic
processes. However, the specific function of p27 has yet to be
determined.
Clone A430075K09 represents a potential new member
of a group of structurally related interferon-inducible pro-
teins, the Ifi 200 cluster, that regulate biological activities of
IFNs. The IFNs are immune response modulating cytokines
that exhibit antiviral effects, induce expression of class I or
class II major histocompatibility complex proteins, and help
activate macrophages, natural killer cells, and neutrophils. Se-
Table 1. The List of 54 Clones Representing 27 Known Interferon-Related Genes in Mouse Found in the FANTOM2 Data Set
Clone ID Mouse strain cDNA library Gene name
1 5830458K16 C57BL/6 Thymus 28-kD interferon  responsive protein
1810013G24 C57BL/6 Pancreas (5830458K16RIK protein) homolog (Mus musculus)
2 0710005K22 C57BL/6 Brain Genes associated with retinoid-IFN-induced mortality 19
0710005K22 C57BL/6 Brain
2700054G14 C57BL/6 Embryo11
2410016H22 C57BL/6 ES
3 A430075E22 C57BL/6 N0 Thymus Interferon ( and ) receptor
4 1100001K09 C57BL/6 18-day embryo Interferon ( and ) receptor 2
2510009P07 C57BL/6 Embryo 13-Liver
5 E430025C02 NOD (NOD)N2 Thymic cells Interferon-activated gene 202A (noncoding RNA)
6 A730048F03 C57BL/6 N7 Cerebellum Interferon-activated gene 205
7 A430077M01 C57BL/6 N0 Thymus Interferon-inducible protein 203 (IFI-203) (interferon-inducible
protein P203)
A530058P16 C57BL/6 Aorta and vein
A530093G11 C57BL/6 Aorta and vein
E430077M01 NOD (NOD)N2 Thymic
8 9030603A05 C57BL/6 Colon Interferon concensus sequence-binding protein
9830117K07 C57BL/6 Bone
9 A830021G01 C57BL/6 N10 Cortex Interferon-dependent positive-acting transcription factor 3 
10 F830002I10 NOD Activated spleen from NOD.Cz Interferon 
F830032O20 NOD Activated spleen from NOD.Cz
11 0610039K12 C57BL/6 Kidney Interferon  induced GTPase
E430012H16 NOD (NOD)N2 Thymic cells
12 5730557A06 C57BL/6 Embryo 8 Interferon  inducible protein 30
13 2010205D02 C57BL/6 Small intestine Interferon  inducing factor-binding protein
1110003K24 C57BL/6 18-day embryo
2310040F23 C57BL/6 Tongue
2310075I12 C57BL/6 Tongue
2310047H18 C57BL/6 Tongue
14 0610011H23 C57BL/6 Kidney Interferon inducible protein 1
15 9830146E22 C57BL/6 Bone Interferon regulatory factor 2
E430001A19 NOD (NOD)N2 Thymic
16 F730005C13 C57BL/6 B6 derived Interferon regulatory factor 4
F830028K14 NOD Activated spleen
17 A130064P06 C57BL/6 N16 Thymus Interferon regulatory factor 6
E230028I05 C57BL/6 P2 oviduct
18 0610039E12 C57BL/6 Kidney Interferon regulatory factor 7
1110062H15 C57BL/6 18-day embryo
A430014N21 C57BL/6 N0 Thymus
F830035B02 NOD Activated spleen
19 2010008K16 C57BL/6 Small intestine Interferon-induced 35-kD protein homolog (IFP 35) homolog
(Mus musculus)
20 2010002M12 C57BL/6 Small intestine Interferon-induced protein with tetratricopeptide repeats 1
F830004H17 NOD Activated spleen
21 A130072L05 C57BL/6 N16 Thymus Interferon-induced protein with tetratricopeptide repeats 2
A630085F01 C57BL/6 N3 Thymus
22 5730412C13 C57BL/6 Embryo 8 Interferon-induced protein with tetratricopeptide repeats 3
5031412D17 C57BL/6 Ovary & Uterus (Preg. 11 day) (IFIT-3) glucocorticoid-attenuated response gene 49
23 F830009I11 NOD Activated spleen interferon-inducible GTPase
24 A430077M01 C57BL/6 N0 Thymus Interferon-inducible protein 203 (Mus musculus)
25 0610030F02 C57BL/6 Kidney Interferon-related developmental regulator 2
26 2900034J12 C57BL/6 Hippocampus Interferon-stimulated protein (15 kD)
27 1600023I01 C57BL/6 Placenta Interferon-stimulated protein (20 kD)
2010006M08 C57BL/6 Small intestine
2010009P14 C57BL/6 Small intestine
2010107M23 C57BL/6 Small intestine
Cytokine-Related Genes in Mouse
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Table 2. The List of 77 Clones Representing 39 Known Interleukin-Related Genes Found in the FANTOM2 Data Set
Clone ID Mouse strain cDNA library Gene name
1 2210418I04 C57BL/6 Stomach Interleukin 1 family, member 5 ()
4632413N13 C57BL/6 Skin (Neonate 0 day)
2310041K07 C57BL/6 Tongue
2310063B08 C57BL/6 Tongue
2 1110033G16 C57BL/6 18-day embryo Interleukin 1 family, member 6 ()
9330131B06 C57BL/6 Diencephalon
9330171A08 C57BL/6 Diencephalon
3 A330066C15 C57BL/6 Spinal cord Interleukin 1 receptor accessory protein
B230304B05 C57BL/6 C.quadrigemina
C630028F01 C57BL/6 Hippocampus
4 F630041P17 NOD NOD-derived Interleukin 1 receptor antagonist
4632427H17 C57BL/6 Skin
5 C130072K02 C57BL/6 E16 Head Interleukin 1 receptor, type I
E230023C01 C57BL/6 P2 oviduct
6 B230327C20 C57BL/6 C.quadrigemina Interleukin 1 receptor-associated kinase
D830047P08 C57BL/6 N16 heart
7 9030010H19 C57BL/6 Colon Interleukin 1 receptor-like 1
8 A530048E20 C57BL/6 Aorta and vein Interleukin 10 receptor, 
9 1500012D04 C57BL/6 Cerebellum Interleukin 10-related T cell-derived inducible factor
10 A430092F05 C57BL/6 N0 Thymus Interleukin 12 receptor,  1
11 A430056E01 C57BL/6 N0 Thymus Interleukin 12 receptor,  2
A530070O09 C57BL/6 Aorta and vein
12 C430004G12 C57BL/6 E7 whole body Interleukin 13 receptor,  1
G430044I06 C57BL/6 Mixeda
13 F830008L10 NOD Activated spleen Interleukin 13 receptor,  2
14 D630025K20 C57BL/6 N0 kidney Interleukin 15
A530045E03 C57BL/6 Aorta and vein
15 A530048H17 C57BL/6 Aorta and vein Interleukin 15 receptor,  chain
A630048I20 C57BL/6 N3 Thymus
16 A130095H14 C57BL/6 N16 Thymus Interleukin 16
17 9830138F10 C57BL/6 Bone Interleukin 17 receptor
A530085G20 C57BL/6 Aorta and vein
18 1110006O16 C57BL/6 18-day embryo Interleukin 17B
19 E030029C19 C57BL/6 N0 lung Interleukin 18 receptor 1
F630101C07 NOD NOD-derived
20 E030025K24 C57BL/6 N0 lung Interleukin 18 receptor accessory protein
21 E430021B09 NOD (NOD) N2 Thymic Interleukin 2 receptor,  chain
A130010M06 C57BL/6 N16 Thymus
22 5430409O05 C57BL/6 Head (Neonate 6 day) Interleukin 2 receptor,  chain
9530010F16 C57BL/6 U.bladder
23 A130027N13 C57BL/6 N16 Thymus Interleukin 2 receptor,  chain
24 7530415H19 C57BL/6 Eyeball (adult) Interleukin 20
25 A430056E07 C57BL/6 N0 Thymus Interleukin 21 receptor
26 A830047G15 C57BL/6 N10 Cortex Interleukin 23,  subunit p19
27 1110033L24 C57BL/6 18-day embryo Interleukin 25
2210408F01 C57BL/6 Stomach
2010016N09 C57BL/6 Small intestine
5830455M19 C57BL/6 Thymus
28 9330197K12 C57BL/6 Diencephalon Interleukin 4 receptor, 
A630083M23 C57BL/6 N3 Thymus
E430003K23 NOD (NOD) N2 Thymic
29 F830019G17 NOD Activated spleen from
NOD.Cz Idd3
Interleukin 6
30 9530096I01 C57BL/6 U.bladder Interleukin 6 receptor, 
B230372K20 C57BL/6 C.quadrigemina
C230031H18 C57BL/6 N0 Cerebellum
31 A430091K05 C57BL/6 N0 Thymus Interleukin 7
A530098I02 C57BL/6 Aorta and vein
A630007F02 C57BL/6 N3 Thymus
D430026C11 C57BL/6 E13 lung
32 A430089D02 C57BL/6 N0 Thymus Interleukin 7 receptor
A530022C19 C57BL/6 Aorta and vein
A630041A17 C57BL/6 N3 Thymus
A630076J23 C57BL/6 N3 Thymus
33 E430023N04 NOD (NOD) N2 Thymic Interleukin 9 receptor
34 2700043J07 C57BL/6 Embryo 11 Interleukin enhancer-binding factor 2
3000002D13 C57BL/6 Embryo 12-head
6230405A16 C57BL/6 Head (embryo 11)
6330441H14 C57BL/6 Medulla
B130010B06 C57BL/6 Partenogenetic
(continued)
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quence of the clone A430075K09 shows similarity (84.9%ID,
425 amino acids, 100% of the total length) to the Ifi 205, the
new member of the Ifi 200 family (Table 5 and Fig. 4, supple-
mental research data; available online at www.genome.org).
Little is known about the precise function of the Ifi 205. How-
ever, it contains the PAAD/DAPIN/Pyrin domain (Pfam
02758), which is present in other members of the Ifi 200 fam-
ily, indicating a possible protein–protein interaction site. This
domain was predicted to have the same six -helices-
containing fold as the well-described Death Domain (Pfam
00531). The death domain is present in the TNFR-1 and FAS/
APO1 receptors involved in cell death (Hofmann and
Tschopp 1995). The potential functions of our candidate
novel Ifi 205 factor, therefore, is the inhibition of cell prolif-
eration and the arrest of cell growth, possibly through modu-
lation of the activity of several transcription factors (Gribaudo
et al. 1999).
Sequence of the clone 5330409J06 showed a weak simi-
larity (Table 5 and Fig. 5, supplemental research data) to the
guanylate-binding protein 5—GBP5 (P26376), published only
as a database entry (GenBank AF288815). To our knowledge,
the function and structure of GBP5 has not been described or
published. In humans, the members of the GBP family are the
most abundant class of proteins induced by IFN- (Prakash et
al. 2000). GBPs have the ability to hydrolyze guanosine tri-
phosphate (GTP) to both mono- (GMP) or di-phosphate
(GDP) products (Schwemmle and Staeheli 1994) involved in
cellular signal transduction. However, little is known about
either the specific biological function of GBPs or their cellular
localization (Vestal et al. 2000). Members of the GBP family
were reported to have antiviral properties (Anderson et al.
1999), play a role in the macrophage activation processes
(Han et al. 1998), and inhibit proliferation of endothelial cells
(Guenzi et al. 2001). The clone 5330409J06 contains GBP
(Pfam 002263) and GBP-C (Pfam 02841) domains. It is there-
fore a strong candidate for a novel gene—the mouse guanyl-
ate-binding protein mGBP-5.
Interleukin-Related Novel Gene Candidates
Sequence of the clone B430113A10 contains Toll/Interleukin
receptor TIR domain structure and shows similarity (88%
identity in 123 AA overlap) to the hypothetical 14.3-kD pro-
tein in long-tailed macaque (Table 5 and Fig. 6, supplemental
research data). The TIR domain (Pfam 01582) is an intracel-
lular-signaling domain found in MyD88, interleukin 1 recep-
tor, and the Toll receptor. The Toll/Interleukin receptor do-
main is associated with a family of proteins that are involved
in early responses to injury and infection (e.g., interleukin-1
receptor) (Slack et al. 2000). The Toll-like receptors in insects
and mammals mediate innate defensive responses against a
variety of microbial products (Anderson 2000). The clone
B430113A10 thus represents a hypothetical protein poten-
tially involved in immune responses.
Sequence of the clone 4732448K15 is similar (69% iden-
tity in full-length sequence of 598 AA) to the human IL-1
receptor-associated kinase-2 (IRAK-2), a proximal mediator of
IL-1 signaling (Table 5 and Fig. 7, supplemental research
data). IRAK-2 binds to the IL-1 receptor and is involved in
IL-1-dependent signaling (Muzio et al. 1997). The clone
4232448K15 contains a Death Domain (Pfam 00531) (Hof-
mann and Tschopp 1995) present in many apoptosis pathway
proteins. It also contains a catalytic Protein Kinase domain
(Hanks and Hunter 1995) that has a conserved catalytic core
common in both serine/threonine and tyrosine protein ki-
nases. It is therefore a strong candidate for defining a novel
gene—the mouse interleukin-1 receptor-associated kinase
2—mIRAK-2.
Sequence of the clone E230031K19 is weakly similar
(76.3% identity over 93.3% length) to the human interleukin
20 receptor  isoform 3 (Table 5 and Fig. 8, supplemental
research data). The conceptual translation (amino acids
1–292, PFAM 01108) contains a tissue factor motif (Muller et
al. 1996) that is involved in blood coagulation. IL-20 was re-
ported to be overexpressed in transgenic mice that have skin
abnormalities similar to psoriatic lesions in humans (Du-
moutier and Renauld 2002).
Growth Factor-Related Novel Gene Candidates
The FANTOM2 clone D430010O15 is a representative of a
cluster (TIEG2-like) that showed similarity to human TGF-
inducible early growth response protein 2 (TIEG2) (Table 5
and Fig. 9, supplemental research data). The conceptual trans-
lation of 9830142A17 showed a slightly higher similarity
(75% identity) to the human, than to mouse TIEG2 (O89091)
(74% identity). TIEG2 is ubiquitously expressed in human
tissues, enriched in pancreas and muscle (Cook et al. 1998).
Similarly, the TIEG2-like FANTOM2 clones were derived from
eight different libraries. The TIEG2-like clone has a conserved
zinc finger domain. TIEG2 is involved in cell growth, and its
overexpression in hamster ovary cells inhibits cell prolifera-
tion (Cook et al. 1998).
Sequence of the clone 4921501K24 showed similarity—
93.7% identity over the full length—(Table 5 and Fig. 10,
supplemental research data) to TGF--induced factor 2
(TGIF2), a homeobox gene of the TALE superclass, thought to
play a role in the development and progression of some ovar-
ian tumors through a gene-amplification mechanism (Imoto
et al. 2000). TGIF2 was shown to repress TGF--responsive
Table 2. Continued
Clone ID Mouse strain cDNA library Gene name
35 5730447J21 C57BL/6 Embryo 8 Interleukin enhancer-binding factor 3
C130034D23 C57BL/6 E16 Head
E430021F21 NOD (NOD) N2 Thymic
36 3200002B17 C57BL/6 Embryo (14+17)-Head Interleukin-four induced gene 1
E330015O10 C57BL/6 P2 ovary
37 E130317D06 C57BL/6 N0 eyeball Nuclear factor, interleukin 3, regulated
38 C130076J06 C57BL/6 E16 Head Mus musculus IL-1F9 (IL1F9)
39 1110054H05 C57BL/6 18-day embryo Mus musculus similar to Interleukin enhancer-binding factor 1
aMixed library (AL,AK,AD,AF,AG,AC,AE,AQ,AP,AH,AA,AO,AB,AI,AJ,AN,AM).
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Table 3. The List of 61 Clones Representing 23 Known Growth Factor-Related Genes Found in the FANTOM2 Data Set
Clone ID Mouse strain cDNA library Gene name
1 D730020G24 C57BL/6 L2 mammary Epidermal growth factor
D430013M15 C57BL/6 E13 lung
E430016A08 NOD (NOD) N2 Thymic cells
2 1300005M11 C57BL/6 Liver Epidermal growth factor receptor (Epidermal growth factor
1300008I23 C57BL/6 Liver receptor isoform 3) homolog (Mus musculus)
1300003K07 C57BL/6 Liver
3 C630023M09 C57BL/6 Hippocampus Epidermal growth factor receptor pathway substrate 15
4 9430061P05 C57BL/6 Upper body Epidermal growth factor receptor pathway substrate 15,
related sequence
5 9430070A01 C57BL/6 E12 Upper body Epidermal growth factor receptor pathway substrate 15,
related sequence
6 9830147J04 C57BL/6 Bone Epidermal growth factor receptor pathway substrate 15,
9830168E22 C57BL/6 Bone related sequence
7 5230401N02 C57BL/6 Xiphoid Epidermal growth factor-containing fibulin-like extracellular
matrix protein 1
8 0610011K11 C57BL/6 Kidney Epidermal growth factor-containing fibulin-like extracellular
matrix protein 2
9 0610042A18 C57BL/6 Kidney Eukaryotic translation initiation factor 3 subunit 2 (EIF-3 )
2410126D05 C57BL/6 ES (EIF P36) (TGF- receptor interacting protein)
2700045C12 C57BL/6 Embryo 11 (TRIP-1) homolog (Mus musculus)
4930503E24 C57BL/6 Testis
10 1190024F07 C57BL/6 18-day embryo Fibroblast growth factor (acidic) intracellular-binding protein
2010004G08 C57BL/6 Small intestine
D930040K23 C57BL/6 E15 head
2810001F12 C57BL/6 Embryo 10 + Embryo 11
2010005N21 C57BL/6 Small intestine
3010027N18 C57BL/6 Embryo 12-Head
G430069F17 C57BL/6 Mixeda
11 5730551C10 C57BL/6 Embryo 8 Fibroblast growth factor 15
D030003J18 C57BL/6 Embryo 9
D230045H09 C57BL/6 E12 eyeball
12 0610042J09 C57BL/6 Kidney Fibroblast growth factor inducible 14
13 2810484E09 C57BL/6 Embryo 10 + Embryo 11 Fibroblast growth factor-regulated protein 2
1110020J11 C57BL/6 18-day embryo
14 9630030D05 C57BL/6 N16 Latent transforming growth factor -binding protein 1
E330034H12 C57BL/6 P2 ovary
C730041O04 C57BL/6 SV40T antigen
9830146M04 C57BL/6 Bone
E230007P04 C57BL/6 P2 oviduct
15 1810044G20 C57BL/6 Pancreas Latent transforming growth factor -binding protein 3
A230048E14 C57BL/6 Hypothalamus
B430105M07 C57BL/6 Adipose
16 E130107B17 C57BL/6 N0 eyeball MEGF 12 homolog (Mus musculus)
17 E130317D06 C57BL/6 N0 eyeball Nuclear factor, interleukin 3, regulated
18 1300004O05 C57BL/6 Liver TGF-inducible early growth response
A730095A08 C57BL/6 N7 Cerebellum
A430010P14 C57BL/6 N0 Thymus
19 1100001I05 C57BL/6 18-day embryo Transforming growth factor  1-induced transcript 1
A530093G23 C57BL/6 Aorta and vein
D430029G15 C57BL/6 E13 lung
E030027O16 C57BL/6 N0 lung
20 1110002A05 C57BL/6 E13 lung Transforming growth factor -regulated gene 1
2610001N22 C57BL/6 Embryo 10
2610029J18 C57BL/6 Embryo 10
21 D230045E03 C57BL/6 E12 eyeball Transforming growth factor, -induced, 68 kD
22 1700105F20 C57BL/6 Testis Transforming growth factor,  receptor I
4930438I19 C57BL/6 Testis
1700105F20 C57BL/6 Testis
23 5730530B02 C57BL/6 Embryo 8 Hypothetical 30.1-kD protein (TGF  inducible nuclear protein
6720481N02 C57BL/6 Extra testis (embryo 12) TINP1) (hairy cell leukemia protein) (Homo sapiens)
2310004E21 C57BL/6 Tongue
2810027P06 C57BL/6 Embryo 10 + Embryo 11
3200001B21 C57BL/6 Embryo (14 + 17)-Head
0610010G24 C57BL/6 Kidney
5730530B02 C57BL/6 Embryo 8
aMixed library (AL,AK,AD,AF,AG,AC,AE,AQ,AP,AH,AA,AO,AB,AI,AJ,AN,AM).
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transcription through interaction with a TGIF-binding site in
DNA (Melhuish et al. 2001).
Little is known about the integrin -like 1 homolog (with
EGF-like repeats), that showed similarity to the clone
B930011D01 (Table 5 and Fig. 11, supplemental research
data). The EGF-like domain is characteristic for extracellular
domain of membrane-bound proteins (InterPro entry
IPR000561). This product may possibly function as a cell-
adhesion receptor.
The conceptual translation of clone E330012C08 showed
similarity (Table 5 and Fig. 12, supplemental research data) to
the human latent TGF--binding protein 4S, LTBP-4
(O75412). The LTPB-4 is a high molecular weight calcium-
binding protein with EGF-like repeats. The cDNA of the
LTBP-4 was found in several different forms generated by al-
ternative splicing (Saharinen et al. 1998), consistent with the
suspected frame shift positions found in the clone
E330012C08. TGF- proteins are multifunctional growth fac-
tors excreted as inactive precursors forming large protein
complexes. These complexes include, among others, LTBPs
which are believed to regulate both local tissue deposition of
TGF- and the related signaling (Sterner-Kock et al. 2002). The
disruption of LTBP-4 in mice leads to ailments such as severe
pulmonary emphysema, cardiomyopathy, and colorectal can-
cer (Sterner-Kock et al. 2002).
Finally, the conceptual translation of clone 9130025L13
showed similarity (Table 5 and Fig. 13, supplemental research
data) to the human FGF receptor 4B—FGFR4b (Q9BXY2). FGF
receptors are involved in multiple hormonal and proliferative
processes of hormonal cells (Yu et al. 2002). A variant of the
FGF receptor 4, related to the FGFR4b was found to increase
tumor cell motility (Bange et al. 2002).
DISCUSSION
The mouse is the most popular model organism for both basic
and applied immunological studies, including the study of
cytokines. Our analysis of the FANTOM2 data set focused on
the subset of transcripts that showed similarity to the cyto-
kine-related products, and which had cytokine names or ab-
breviations in the name or description fields of the corre-
sponding database entries (the cytokine-name criterion). Our
study is only partial because databases include cytokine-
related entries of genes and proteins that do not have an
explicit cytokine name in the name or description fields.
However, this study is representative because it focused on a
well-defined subset of cytokine-related genes from which we
can make an estimate of the coverage of cytokine-related
genes in the FANTOM2 data set.
In comparison with database entries that conform to the
cytokine-name criterion, we estimate that the ratio of cyto-
kine-related products represented in the FANTOM2 data set is
of the order of 20% of the total known cytokine-related prod-
ucts. This estimate is not surprising, because cytokines are
inducible and often tissue-specific products. In addition, even
when induced, the expression level of cytokines is often very
low. The RIKEN libraries, although diverse, may not represent
the optimal conditions required for induction of cytokines
and their related genes. The regulatory processes involving
cytokines are complex processes involving activation and
suppression of multiple genes (Doly et al. 1998; Munshi et al.
Table 4. The List of 30 Clones Representing 19 Known Small Inducible Cytokine-Related Genes Found in the FANTOM2 Data Set
Clone ID Mouse strain cDNA library Gene name
1 1810065I01 C57BL/6 Pancreas Small inducible cytokine A1
2 2310074D07 C57BL/6 Tongue Small inducible cytokine A11
2310011L12 C57BL/6 Tongue
3 2700043D19 C57BL/6 Embryo 11 Small inducible cytokine A12
4 1600023B02 C57BL/6 Placenta Small inducible cytokine A27
1600002M16 C57BL/6 Placenta
5 4921506E08 C57BL/6 Testis Small inducible cytokine A28
6 1010001B04 C57BL/6 Heart Small inducible cytokine A5
7 0610030C20 C57BL/6 Kidney Small inducible cytokine A6
2010308M07 C57BL/6 Small intestine
8 8430433J09 C57BL/6 Lung (embryo 16) Small inducible cytokine A7
9 1810063B20 C57BL/6 Pancreas Small inducible cytokine A8, MCP-2
10 1810031C02 C57BL/6 Pancreas Small inducible cytokine A17
11 A430095C13 C57BL/6 N0 Thymus Small inducible cytokine A20
12 A930010L22 C57BL/6 Retina Small inducible cytokine B, member 5
13 A630052H15 C57BL/6 N3 Thymus Small inducible cytokine B (Cys-X-Cys), member 9
A630095J17 C57BL/6 Thymus
14 A430052M02 C57BL/6 N0 Thymus Small inducible cytokine B (Cys-X-Cys), member 11
A430101A17 C57BL/6 N0 Thymus
C730001K22 C57BL/6 SV40T antigen transgenic
mouse
15 4631412M08 C57BL/6 (EST_a) Skin (Neonate 0 day) Small inducible cytokine B (Cys-X-Cys), member 13
16 1110012L01 C57BL/6 (EST_a) 18-day embryo Small inducible cytokine B (Cys-X-Cys), member 14
1110031L23 C57BL/6 18-day embryo
1200006I23 C57BL/6 Lung
2810410F08 C57BL/6 Embryo 10 + Embryo 11
3300001J19 C57BL/6 Embryo 17-Head
17 3110001P14 C57BL/6 Embryo 13-Head Small inducible cytokine B, member 15
18 A430076J21 C57BL/6 N0 Thymus C, member 1 (lymphotactin)
19 6430571D05 C57BL/6 Olfactory brain Small inducible cytokine D, 1
A430078J23 C57BL/6 N0 Thymus
Cytokine-Related Genes in Mouse
Genome Research 1313
www.genome.org
 Cold Spring Harbor Laboratory Press on September 30, 2015 - Published by genome.cshlp.orgDownloaded from 
1999; Vanden Berghe et al. 2000). This illustrates the need for
creating more specific cDNA libraries that dynamically cap-
ture gene expression profiles for the study of the cellular pro-
cesses involving cytokines.
It is not always possible, particularly in large-scale stud-
ies, to derive clear conclusions and explanations of the data.
Our selection of the threshold that distinguishes novel from
the known genes or gene candidates is arbitrary. The clone
representing integrin -like homolog (Fig. 11, supplemental
research data) has only 10 amino acid differences to its refer-
ence sequence. Such clones may, therefore, represent variants
or merely the inter-strain differences of the same transcript.
Three of the clones representing the 1-8 family of IFN-
inducible proteins (Fig. 1) do not appear to be full length and
may represent poor-quality sequence data. We should also be
aware of the possible problems with the reference data. The Ifi
205 reference sequence (Fig. 4, supplemental research data)
has a triple repeat of the sequence AGSTAQ, which is missing
in the corresponding FANTOM2 clone. This may possibly rep-
resent a sequencing artifact in the reference sequence. Con-
versely, the FANTOM2 clone having sequence similarity to
human latent TGF- binding protein (Fig. 12, supplemental
research data) contains P+R-rich regions that are not present
in the reference sequence and may represent artifacts. Map-
ping FANTOM2 clones to the mouse genome sequence at
Ensembl (Hubbard et al. 2002) indicated that some of the
FANTOM2 clones represented clear hits, whereas others, (es-
pecially Ifi 200 clones) had multiple hits. The multiple hits
results may be explained by possible artifacts or poor se-
quence data, but may also represent the complexity of tran-
scriptional regulation of inducible genes warranting further
investigation.
Table 5. The List of Candidate Novel Cytokine Related Genes Represented in the FANTOM2 Data Set
Clone ID DDBJa cDNA library Similarityb Similar gene name
1 1110004C05c 18-day embryo 89.8, 100.0 (145 AA) Interferon-inducible protein (Rattus norvegicus).
1810060G19 AK003507 Pancreas 89.1, 100.0 Identical to 1110004C05RIK protein (Q9CQW9)
1810061A10 Pancreas 89.8, 100.0
2 4930507H06c AK076846 Testis 73.1, 75.9 (145 AA) Interferon-inducible protein (Rattus norvegicus).4933438K12 Testis 64.8, 89.0 Identical to 4933438K12RIK protein (Q9D3R8)
3 A330075D07c AK039626 Spinal cord 52.8, 81.8 (145 AA) Interferon-induced transmembrane protein 2
(interferon-inducible protein 1-8D) (Homo sapiens)
4 1110036C17c AK004121 18-day embryo 72.9, 78.1 (145 AA) Homolog to interferon-inducible protein
5 2310061N23c AK010014 Tongue 78.0, 97.6 (84 AA) -interferon inducible protein (fragment)
(Mesocricetus auratus)
6 A430075K09c AK040191 N0 Thymus 84.9, 100.0 (425 AA) Interferon-activatable protein 205 (IFI-205), also9830003L02 Bone 77.3, 77.3 known as D3 protein (Mus musculus). Contains
PAAD/DAPIN/ Pyrin domain (Pfam 02758) and the
associated HIN-200/IF120x domain.
7 5330409J06c
AK030414
Pituitary gland 69.0, 93.6 IF-induced GUANYLATE-BINDING PROTEIN 5
9530054H01 U. bladder 65.1, 29.3 (Homo sapiens)
E030025M22 N0 lung 69.0, 93.6 (551 AA)
8 B430113A10c AK080873 Adipose 87.6, 100.0 (123 AA) Hypothetical Toll/Interleukin receptor TIR domain
structure containing protein
9 4732448K15c
AK028733
Skin (Neonate 10 day) 68.8, 100.0 (598 AA) Interleukin-1 receptor-associated kinase 2
9130227N12 Cecum 75.5, 24.2 (Homo sapiens)
6330415L08 Medulla oblongata 64.9, 100.0
10 E230031K19c AK054215 P2 oviduct 76.3, 93.3 (556 AA) Interleukin 20 receptor  isoform 3 (Homo
sapiens)
11 9830142A17
C330038O18
C730023J20
D430010O15c
A230003P18
D630011E14
E230024J15
E430037H02
AK084913
Bone
ES cells
SV40T antigen transgenic
E13
Hypothalamus
N0 kidney
P2 oviduct
(NOD)N2 Thymic cells
75.2, 99.8 (512 AA)
75.0, 99.8
75.4, 99.8
75.0, 99.8
75.2, 99.8
75.0, 99.8
75.2, 99.8
75.1, 99.8
Transforming growth factor--inducible early growth
response protein 2 (TGF-inducible early growth
response protein 2) (TIEG-2) (Kreppel-like factor
11) (Homo sapiens)
12 4921501K224c
5730599O09 AK076631
Testis
Embryo 8
93.7, 100.0 (237 AA)
89.9, 100.0
DJ977B1.4.1 (isoform 1) (TGIF2) (TGF-induced factor 2)
(TALE family homeobox)) homolog (Homo sapiens)
13 B930011D01c AK047014 N10 Cerebellum 88.2, 84.4 (153 AA) Integrin, -like 1 (with EGF-like repeat domains)
homolog (Mus musculus)
14 2310046A13c
E330012C08
A730031D03
AK054297
Tongue
P2 ovary
N7 Cerebellum
88.3, 26.7
88.8, 96.5 (1505 AA)
95.4, 32.5
Latent transforming growth factor--binding protein
4S homolog (Homo sapiens)
15 9130025L13c
9530005F04 AK033606
Cecum
U. bladder
77.1, 99.5 (423 AA)
62.8, 99.5
FGF receptor 4B (Homo sapiens)
Thirty-one clones representing fourteen candidate new genes.
aDDBJ accession no. of the representative transcript.
bSimilarity was defined by two parameters, first the percent identity and second the percent of the length of the reference sequence
(similar-gene) having similarity to the FANTOM2 clone. The number in the parentheses in the SIMILARITY field shows the length of the
alignment or the maximum length of multiple alignment. All clones were derived from the mouse strain C57BL/6, except for clone
E430037H02, which was derived from NOD mouse.
cRepresentative transcripts.
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Computational analysis has been applied previously to
identification of novel cytokines from EST libraries, such as
cardiotrophin-like cytokine (Shi et al. 1999). We have shown
that this process can be enhanced by using the elimination
strategy that involves multiple consecutive steps as follows:
generation of multiple cDNA libraries, large-scale computa-
tional annotation, human curation, identification of relevant
subsets of sequences, and individual clone analysis. This pro-
cess involves a number of elimination steps—it is therefore
critical that the loss of information is kept at a reasonable
level. Too stringent criteria for elimination of clones from
further analysis would lead to a small number of clones hav-
ing a high-quality and high-confidence annotation. On the
other hand, this would lead to the elimination of clones that
represent results of complex transcriptional events, modifica-
tions, or variants. Too lenient criteria for the inclusion of
clones for further analysis may lead to the proliferation of
artifacts and errors into sequence data. To minimize the pro-
liferation of errors, we excluded a number of clones from the
analysis, including those that contained stop codons (data
not shown).
We identified 15 candidates for novel cytokine-related
genes. Because many cytokine-related genes do not contain
cytokine names in their description, this should represent
only a fraction of the novel cytokine-related candidate genes
captured by the FANTOM2 library. Further strategies will in-
volve making comprehensive lists of cytokine-related genes
followed by comparison of these genes with the existing
cDNA libraries and future cDNA libraries designed for captur-
ing specific gene expression during the immune processes.
METHODS
The FANTOM2 set of full-length mouse cDNA clones, referred
to as clones in this text, contains 60,770 sequences with the
total length of almost 120 million base pairs and more
than 12 million conceptually translated amino acids. The
FANTOM2 clones were functionally annotated using auto-
matic computational annotation followed by expert human
curation (Okazaki et al. 2002). The overall process of identi-
fication of novel candidate genes is shown in Fig. 3).
Sequence Analysis
The sequences of the cDNA clones were compared with the
genetic, protein, motif and protein domain databases. The
genetic databases used for the analysis of clones included
GenBank (Benson et al. 2002), LocusLink (Wheeler et al.
2002), UniGene (Wheeler et al. 2002), Mouse Genome Data-
base (MGD) (Blake et al. 2002), and TIGR databases (Quack-
enbush et al. 2001). The comparisons to the genetic databases
were performed using the nucleotide to nucleotide sequence
local alignment algorithm BLASTN (Altschul et al. 1990). The
protein databases used for the analysis of FANTOM2 clones
included SWISS-PROT and TrEMBL (Bairoch and Apweiler
2000), and PIR (Wu et al. 2002). The comparisons were per-
formed using the program FASTY (Pearson et al. 1997) that
compares a DNA sequence with protein sequences in a data-
base. FASTY translates a DNA sequence in three frames and
aligns the translations to each sequence in the protein data-
base, permitting gaps and frame shifts. Finally, the FANTOM2
clones were compared with the SCOP (Lo Conte et al. 2002),
Pfam (Bateman et al. 2002), and InterPro (Apweiler et al.
2001) databases for identification of potential protein do-
mains and functional sites, and to the MDS (Maximum Den-
Figure 2 Candidate novel gene represented by clone 2310061N23 similar to the fragments of IFN- inducible proteins in human (Q9H2X8) and
hamster (Q9QXH3). (+) Conserved replacements.
Figure 1 The alignment of conceptual translations of the four candidate novel mouse genes of the family 1-8 of IFN-inducible proteins with
representative sequences from rainbow trout (Q8QFL3) and rat (Q9R175). A conserved motif characteristic for the members of interferon-induced
1-8 family of proteins in mice, rats, humans, cattle, and trout is shown with the alignment. Capital letters in the consensus motif stand for identical
residues, + for conserved residues (aliphatic—I,V,L, or M; positively charged—K or R; aromatic—F,Y, or W), and x for any residue. The ubiquitin-
conjugating enzyme E2 active site motif in 1810061A10 [25] and a similar motif in 4930507H06 are shaded. SPTR stands for SWISS-PROT/TrEMBL
database [15], and RI stands for RIKEN clone.
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sity Subgraph) Motif Database (Kawaji et al. 2002) for the
presence of potential protein motifs. Unless specified other-
wise, the gene products references throughout the text corre-
spond to SWISS-PROT and TrEMBL (SPTR) primary accession
numbers.
Functional Annotation and Identification
of FANTOM2 Clones
Functional annotation of clones was performed in three steps
as follows: data mining, manual annotation, and sequence
analysis of the selected clones followed by literature text
searching. First, the data-mining step involved a large-scale
sequence comparison using BLASTN or FASTY against all of
the selected databases. The results of these searches were ac-
cessible to the annotators via the FANTOM2 graphical inter-
face, providing a convenient tool for the second step, the
manual annotation. The most likely coding sequences (CDS)
were determined by comparison of the results of four predic-
tion programs (ProCrest, Decoder, rsCDS, and NCBI cds). Ad-
ditional tools, such as ClustalW (Thompson et al. 1994) were
available for facilitation of the functional annotation. The
annotation results were then summarized and searched by
keywords cytokine, interferon, IF, IFN, interleukin, IL, trans-
forming growth factor, TGF, epidermal growth factor, EGF,
fibroblast growth factor, and FGF. The clones that showed
50%–95% identity to the known cytokine-related genes were
considered as candidate novel genes and were further ana-
lyzed using the programs BLAST or FASTA. The clone
A530093G11 was also included in analysis, because its con-
ceptual translation showed 96% identity over the 50% of the
reference sequence length. Finally, literature searches in the
PubMed (Wheeler et al. 2002) were performed for identifica-
tion of key publications. The possible functions of the candi-
date novel genes were elucidated from literature sources.
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